Results 261 to 270 of about 276,260 (291)
Some of the next articles are maybe not open access.
Veterinary dermatology (Print), 2020
BACKGROUND Allergen-specific immunotherapy (ASIT) is the only causative treatment of canine atopic dermatitis (cAD). Different routes for administration of ASIT have been used; however, comparative studies are lacking. HYPOTHESIS/OBJECTIVES The present
N. Fischer, A. Rostaher, C. Favrot
semanticscholar +1 more source
BACKGROUND Allergen-specific immunotherapy (ASIT) is the only causative treatment of canine atopic dermatitis (cAD). Different routes for administration of ASIT have been used; however, comparative studies are lacking. HYPOTHESIS/OBJECTIVES The present
N. Fischer, A. Rostaher, C. Favrot
semanticscholar +1 more source
Adherence to Sublingual Immunotherapy
Current Allergy and Asthma Reports, 2016Adherence is a major issue in any medical treatment. Allergen immunotherapy (AIT) is particularly affected by a poor adherence because a flawed application prevents the immunological effects that underlie the clinical outcome of the treatment. Sublingual immunotherapy (SLIT) was introduced in the 1990s, and the early studies suggested that adherence ...
Incorvaia, Cristoforo +3 more
openaire +3 more sources
Sublingual immunotherapy: update 2006
Current Opinion in Allergy & Clinical Immunology, 2006Sublingual immunotherapy is currently accepted as a viable therapeutic option, and is widely used in many European countries. In the past 2 years, new data concerning clinical, immunological and practical aspects of sublingual immunotherapy have been published, and many critical points have been addressed.In addition to the new data on clinical ...
PASSALACQUA, GIOVANNI, CANONICA, GIORGIO
openaire +3 more sources
Sublingual Immunotherapy: Other Indications
Immunology and Allergy Clinics of North America, 2011Sublingual immunotherapy (SLIT) represents a significant advance and it seems particularly suitable in pediatric patients. There are favorable results for food allergy in controlled trials. For latex allergy, the results of several trials are encouraging. For atopic dermatitis, previous experience with subcutaneous immunotherapy and some earlier trials
PASSALACQUA, GIOVANNI +2 more
openaire +2 more sources
Predictors of Completion of Sublingual Immunotherapy
The Laryngoscope, 2020Sublingual immunotherapy (SLIT) has emerged as an effective treatment alternative to subcutaneous immunotherapy (SCIT) given its improved safety profile and more convenient dosing.
Nanki Hura +4 more
semanticscholar +1 more source
Clinical Otolaryngology, 2020
Allergic rhinitis (AR) is a common inflammatory condition of the nasal mucosa affecting approximately 20% of the population worldwide. Current therapies include intranasal antihistamines, corticosteroids, subcutaneous and sublingual immunotherapy (SLIT).
Dominika Boldovjáková +8 more
semanticscholar +1 more source
Allergic rhinitis (AR) is a common inflammatory condition of the nasal mucosa affecting approximately 20% of the population worldwide. Current therapies include intranasal antihistamines, corticosteroids, subcutaneous and sublingual immunotherapy (SLIT).
Dominika Boldovjáková +8 more
semanticscholar +1 more source
Early Response of Specific IgE can Predict Satisfaction with Sublingual Immunotherapy
The Laryngoscope, 2020To investigate predictive parameters at baseline and during the early response to sublingual immunotherapy (SLIT) for house dust mites in allergic rhinitis patients.
Jin Youp Kim +5 more
semanticscholar +1 more source
Immunotherapy, 2019
Aim: We investigated sublingual immunotherapy for mite-induced allergic rhinitis and its comorbid allergic conditions. Patients & methods: A prospective case-controlled study of 120 patients (case = 80, control = 40) over 12 months. Results: There was 53.
A. Chan, W. Luk, L. Fung, T. Lee
semanticscholar +1 more source
Aim: We investigated sublingual immunotherapy for mite-induced allergic rhinitis and its comorbid allergic conditions. Patients & methods: A prospective case-controlled study of 120 patients (case = 80, control = 40) over 12 months. Results: There was 53.
A. Chan, W. Luk, L. Fung, T. Lee
semanticscholar +1 more source
A case series of sublingual immunotherapy-induced eosinophilic esophagitis: stop or spit
Clinical Journal of Gastroenterology, 2021Y. Fujiwara +9 more
semanticscholar +1 more source